Using AI to identify early risk
At Lynne Fernandes Optometrists, we're proud to be at the forefront of innovation, which is why we are collaborating with Bitfount and Bristol Eye Hospital. Bitfount is a healthcare technology leader in ethical AI, and this collaboration demonstrates our commitment to the future of eye health through personalised, predictive and preventative care.
Pioneering early detection of Macular Degeneration
Bitfount’s technology is helping us securely and ethically search our patient database. This search will help identify individuals who may be suitable for a new treatment trial for Geographic Atrophy, a late-stage form of dry Age-Related Macular Degeneration (AMD).
Until very recently, Geographic Atrophy was considered untreatable. But exciting breakthroughs in research are changing the landscape, and we’re proud to play a role in bringing these opportunities to our patients.
How Bitfount’s AI supports early intervention
Bitfount’s ethical AI platform securely searches anonymised patient data, helping us to identify individuals who may benefit from taking part in a new treatment trial for Geographic Atrophy. This means earlier detection, more timely support and potentially, access to sight-saving therapies.
Importantly, Bitfount’s technology is designed with data security and patient privacy at its core - something we also care deeply about at every stage of our patients’ journey.
How EyeSense supports long-term eye health
Through EyeSense, our Optometrists already monitor patients for subtle changes in retinal health, using advanced imaging and data-led tracking over time. This places our patients in the best possible position to benefit from medical innovations as they emerge.
Now, with the added power of AI-supported early risk identification, we can act even faster - connecting the right patients with the right care, at exactly the right moment.
Transforming routine eye care into life-changing action
This collaboration highlights how routine optometry can evolve into proactive and personalised healthcare. With the right tools and partnerships, eye exams become a launchpad for early intervention and long-term protection of your vision.
If you’ve been diagnosed with dry AMD or have concerns about macular changes and you’d like to know more about this trial or how EyeSense supports long-term eye health, please don’t hesitate to contact us or book an eye test.